← Back to Patent Explorer
US7789909B2 Active / In Force US ⏱️ 2.9 years remaining

System for implanting a valve prosthesis

Assignee: Edwards Lifesciences AG
•
Filing: 2009-09-10
•
Granted: 2010-09-07
•
Expires: 2029-09-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A system for implanting a valve prosthesis comprises a compressible and expandable stent with a collapsible and expandable valve structure mounted within the stent. An insertion catheter is provided for advancing the valve prosthesis through a small inlet opening into a body channel The valve structure is preferably formed of biological tissue. The stent may be self-expandable or may be expanded by a balloon on the distal end portion of the catheter. The stent is configured to expand in the body channel such that the outer surface of the stent engages surrounding tissue. After expansion, the valve structure within the stent becomes functional, thereby allowing blood to flow in only one direction. The valve prosthesis is detachable from the catheter for permanent implantation in the body channel. The valve prosthesis is preferably used for replacing the function of a natural heart valve without requiring open heart surgery.

Inventors

  • 👤 Henning Rud Andersen
  • 👤 John Michael Hasenkam
  • 👤 Lars Lyhne Knudsen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:12
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2475; A61F2/2412; A61F2/2418; A61F2/2427; A61F2/243; A61F2/2433; A61F2220/00; A61F2220/0025; A61F2220/005; A61F2220/0058; A61F2230/00; A61F2230/0002; A61F2230/0004; A61F2230/0013; Y; Y10; Y10S; Y10S623/00; Y10S623/90; Y10S623/902; Y10S623/904

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 347 words
A system for replacing the function of a natural heart valve in a human body by a catheterization technique, comprising: an elongate catheter having an opening configured for receiving a guide wire, the catheter sized for advancement into a human heart without opening the thoracic cavity; a self-expandable stent constructed to be radially compressible and re-expandable, the stent having a top end, a bottom end and a metallic outer surface configured to contact native tissue in the human heart; and a collapsible and re-expandable elastical valve comprising three flaps formed of biological tissue, the elastical valve attached to an interior portion of the stent for folding and expanding together with the stent, the elastical valve located between the top and bottom ends of the stent, the elastical valve having three commissural points sutured to the stent, the elastical valve configured to allow blood to flow in one direction such that blood is capable of flowing through the stent from the bottom end toward the top end; wherein the stent and elastical valve are radially compressible from an expanded condition to a compressed condition for advancement through a small inlet opening into a body channel, the stent having a compressed outer diameter of 10 mm or less for placement inside a tubular wall of a cap along a distal end portion of the catheter and wherein the stent is radially self-expandable upon ejection from the cap to a re-expanded condition comprising a re-expanded outer diameter of approximately 27 mm or more such that at least a portion of the stent contacts native tissue in the human heart for securing the stent in the human heart without suturing the stent to native tissue, the stent configured for supporting the elastical valve in the human heart for replacing the function of a natural aortic valve without open heart surgery and wherein the catheter is detachable from the stent and elastical valve such that the catheter can be removed from the human body and the small inlet opening can be closed such that the patient can resume a substantially normal life.
Claim 2
Independent Claim 347 words
A system for replacing the function of a natural heart valve in a human body by a catheterization technique, comprising: an elongate catheter having an opening configured for receiving a guide wire, the catheter sized for advancement into a human heart without opening the thoracic cavity; a self-expandable stent constructed to be radially compressible and re-expandable, the stent having a top end, a bottom end and a metallic outer surface configured to contact native tissue in the human heart; and a collapsible and re-expandable elastical valve comprising three flaps formed of biological tissue, the elastical valve attached to an interior portion of the stent for folding and expanding together with the stent, the elastical valve located between the top and bottom ends of the stent, the elastical valve having three commissural points sutured to the stent, the elastical valve configured to allow blood to flow in one direction such that blood is capable of flowing through the stent from the bottom end toward the top end; wherein the stent and elastical valve are radially compressible from an expanded condition to a compressed condition for advancement through a small inlet opening into a body channel, the stent having a compressed outer diameter of 10 mm or less for placement inside a tubular wall of a cap along a distal end portion of the catheter and wherein the stent is radially self-expandable upon ejection from the cap to a re-expanded condition comprising a re-expanded outer diameter of approximately 27 mm or more such that at least a portion of the stent contacts native tissue in the human heart for securing the stent in the human heart without suturing the stent to native tissue, the stent configured for supporting the elastical valve in the human heart for replacing the function of a natural aortic valve without open heart surgery and wherein the catheter is detachable from the stent and elastical valve such that the catheter can be removed from the human body and the small inlet opening can be closed such that the patient can resume a substantially normal life.
Claim 3
Dependent Claim 20 words
The system of claim 1 , wherein the stent is configured to re-expand along an entire length of the stent.
Claim 4
Dependent Claim 36 words
The system of claim 2 , wherein the elastical valve is sized to be positioned in the human heart between the coronary ostia and the left ventricle for replacing the function of the natural aortic valve.
Claim 5
Dependent Claim 45 words
The system of claim 3 , wherein the stent has sufficient height such that a portion of the stent can be positioned above the coronary ostia while a remaining portion of the stent supports the elastical valve between the coronary ostia and the left ventricle.
Claim 6
Dependent Claim 13 words
The system of claim 4 , wherein the stent has a thread structure.
Claim 7
Dependent Claim 15 words
The system of claim 5 , wherein the thread structure is a grate shaped structure.
Claim 8
Dependent Claim 17 words
The system of claim 6 , wherein the elastical valve comprises biological tissue from a pig heart.
Claim 9
Dependent Claim 23 words
The system of claim 7 , wherein the stent has a stiffness sufficient to prevent a contraction of more than 10% following re-expansion.
Claim 10
Dependent Claim 15 words
The system of claim 1 , wherein the elastical valve is glued to the stent.
Claim 11
Independent Claim 380 words
A system for replacing the function of an aortic valve in an adult human heart using a catheterization technique and without requiring open heart surgery, comprising: a flexible insertion catheter sized for insertion through a small inlet opening and configured for advancement over a guide wire through a body channel; a radially compressible and re-expandable metallic stent having a top end, a bottom end and a metallic outer surface configured to directly contact surrounding native tissue in the body channel with a pressure sufficient to prevent detachment from the body channel; and a radially collapsible and re-expandable valve positioned within an interior portion of the stent and sutured to the stent for folding and expanding together with the stent, the valve having three flaps formed of biological tissue, the three flaps positioned between the top and bottom ends of the stent for allowing blood to flow in one direction such that blood is capable of flowing through the stent from the bottom end toward the top end, the valve having three commissural points sutured to the stent; wherein the stent is radially compressible from an expanded condition to a compressed condition, the compressed condition having a compressed outer diameter of less than 12.5 mm to be located inside a tubular wall of a cap along a distal end portion of the insertion catheter for advancement through the small inlet opening into the body channel and wherein the stent is radially re-expandable upon ejection from the cap to a re-expanded condition comprising a re-expanded outer diameter of approximately 27 mm or larger for securing the stent to the surrounding native tissue without suturing the stent to the surrounding native tissue and wherein the insertion catheter is detachable from the stent and valve such that the insertion catheter can be removed from the body channel and the small inlet opening can be closed and wherein the metallic stent has a sufficient height such that the top end of the stent is capable of being positioned downstream of the coronary ostia for anchoring the top end of the stent to the aorta while the valve is positioned substantially between the coronary ostia and a left ventricle of a heart for replacing the function of the natural aortic valve without requiring open heart surgery.
Claim 12
Independent Claim 380 words
A system for replacing the function of an aortic valve in an adult human heart using a catheterization technique and without requiring open heart surgery, comprising: a flexible insertion catheter sized for insertion through a small inlet opening and configured for advancement over a guide wire through a body channel; a radially compressible and re-expandable metallic stent having a top end, a bottom end and a metallic outer surface configured to directly contact surrounding native tissue in the body channel with a pressure sufficient to prevent detachment from the body channel; and a radially collapsible and re-expandable valve positioned within an interior portion of the stent and sutured to the stent for folding and expanding together with the stent, the valve having three flaps formed of biological tissue, the three flaps positioned between the top and bottom ends of the stent for allowing blood to flow in one direction such that blood is capable of flowing through the stent from the bottom end toward the top end, the valve having three commissural points sutured to the stent; wherein the stent is radially compressible from an expanded condition to a compressed condition, the compressed condition having a compressed outer diameter of less than 12.5 mm to be located inside a tubular wall of a cap along a distal end portion of the insertion catheter for advancement through the small inlet opening into the body channel and wherein the stent is radially re-expandable upon ejection from the cap to a re-expanded condition comprising a re-expanded outer diameter of approximately 27 mm or larger for securing the stent to the surrounding native tissue without suturing the stent to the surrounding native tissue and wherein the insertion catheter is detachable from the stent and valve such that the insertion catheter can be removed from the body channel and the small inlet opening can be closed and wherein the metallic stent has a sufficient height such that the top end of the stent is capable of being positioned downstream of the coronary ostia for anchoring the top end of the stent to the aorta while the valve is positioned substantially between the coronary ostia and a left ventricle of a heart for replacing the function of the natural aortic valve without requiring open heart surgery.
Claim 13
Independent Claim 339 words
A system for replacing the function of a natural cardiac valve, comprising: a flexible elongate delivery catheter having an opening configured to receive a guide wire, the catheter adapted for advancement into a human heart without opening the thoracic cavity; and a valve prosthesis configured to be coupled to a distal end portion of the delivery catheter, the valve prosthesis comprising: a radially compressible and re-expandable stent having a top end, a bottom end and a metallic outer surface configured to contact native tissue in the human heart; and a collapsible and re-expandable valve structure positioned within an interior portion of the stent and sutured to the stent for collapsing and re-expanding together with the stent, the valve structure having three flaps formed entirely of biological tissue, the three flaps positioned between the top and bottom ends of the stent, the valve structure having three commissural points sutured to the stent, the valve structure configured to allow blood to flow in one direction such that blood enters through a bottom opening at the bottom end of the stent and exits through a top opening at the top end of the stent; wherein the valve prosthesis is radially compressible to a compressed state comprising a compressed outer diameter of less than 10 mm for introduction by way of the delivery catheter through an inlet opening into a body channel and wherein the valve prosthesis is radially re-expandable to a re-expanded state comprising a re-expanded outer diameter at least three times larger than the compressed outer diameter and wherein the re-expanded outer diameter is sized to engage native tissue in the human heart with a pressure sufficient for preventing detachment from the human heart and for fixing the valve prosthesis in the human heart without suturing the valve prosthesis to native tissue and wherein the valve prosthesis is detachable from the delivery catheter such that the delivery catheter can be removed from the patient's body and the inlet opening can be closed while the valve prosthesis remains in the human heart.
Claim 14
Independent Claim 339 words
A system for replacing the function of a natural cardiac valve, comprising: a flexible elongate delivery catheter having an opening configured to receive a guide wire, the catheter adapted for advancement into a human heart without opening the thoracic cavity; and a valve prosthesis configured to be coupled to a distal end portion of the delivery catheter, the valve prosthesis comprising: a radially compressible and re-expandable stent having a top end, a bottom end and a metallic outer surface configured to contact native tissue in the human heart; and a collapsible and re-expandable valve structure positioned within an interior portion of the stent and sutured to the stent for collapsing and re-expanding together with the stent, the valve structure having three flaps formed entirely of biological tissue, the three flaps positioned between the top and bottom ends of the stent, the valve structure having three commissural points sutured to the stent, the valve structure configured to allow blood to flow in one direction such that blood enters through a bottom opening at the bottom end of the stent and exits through a top opening at the top end of the stent; wherein the valve prosthesis is radially compressible to a compressed state comprising a compressed outer diameter of less than 10 mm for introduction by way of the delivery catheter through an inlet opening into a body channel and wherein the valve prosthesis is radially re-expandable to a re-expanded state comprising a re-expanded outer diameter at least three times larger than the compressed outer diameter and wherein the re-expanded outer diameter is sized to engage native tissue in the human heart with a pressure sufficient for preventing detachment from the human heart and for fixing the valve prosthesis in the human heart without suturing the valve prosthesis to native tissue and wherein the valve prosthesis is detachable from the delivery catheter such that the delivery catheter can be removed from the patient's body and the inlet opening can be closed while the valve prosthesis remains in the human heart.
Claim 15
Dependent Claim 39 words
The system of claim 11 , further comprising an expandable balloon disposed along the distal end portion of the delivery catheter, the expandable balloon configured to be inflated by injecting fluid through a fluid channel in the delivery catheter.
Claim 16
Dependent Claim 11 words
The system of claim 11 , wherein the stent is self-expandable.
Claim 17
Independent Claim 310 words
A system for replacing the function of a defective natural valve in an adult human, comprising: an elongate insertion catheter having a central opening configured for receiving a guide wire, the catheter sized for advancement over the guide wire and through a body channel; and a compressible and re-expandable stent having an inlet end, an outlet end and a metallic outer surface, the stent being radially compressible from an expanded state to a compressed state for introduction through an inlet opening into a body channel along a distal end portion of the insertion catheter, the stent being re-expandable along an entire length of the stent to a re-expanded state such that the metallic outer surface engages surrounding tissue in the body channel, wherein an outer diameter of the stent in the re-expanded state is at least three times larger than an outer diameter of the stent in the compressed state; and a collapsible and re-expandable valve structure mounted within an interior portion of the stent between the inlet and outlet ends of the stent for folding and expanding together with the stent and configured for preventing blood flow in one direction, the valve structure having movable flaps positioned between the inlet and outlet ends of the stent for allowing blood to flow only from the inlet end toward the outlet end of the stent; wherein stent stiffness provides the sole means of fixation to surrounding tissue for securing the stent and valve structure to the body channel and wherein the stent and valve structure are detachable from the catheter such that the catheter can be removed from the body channel and the inlet opening can be closed such that the stent and valve structure are permanently implantable in the body channel for replacing the function of a natural valve without suturing the stent or valve structure to surrounding native tissue.
Claim 18
Independent Claim 310 words
A system for replacing the function of a defective natural valve in an adult human, comprising: an elongate insertion catheter having a central opening configured for receiving a guide wire, the catheter sized for advancement over the guide wire and through a body channel; and a compressible and re-expandable stent having an inlet end, an outlet end and a metallic outer surface, the stent being radially compressible from an expanded state to a compressed state for introduction through an inlet opening into a body channel along a distal end portion of the insertion catheter, the stent being re-expandable along an entire length of the stent to a re-expanded state such that the metallic outer surface engages surrounding tissue in the body channel, wherein an outer diameter of the stent in the re-expanded state is at least three times larger than an outer diameter of the stent in the compressed state; and a collapsible and re-expandable valve structure mounted within an interior portion of the stent between the inlet and outlet ends of the stent for folding and expanding together with the stent and configured for preventing blood flow in one direction, the valve structure having movable flaps positioned between the inlet and outlet ends of the stent for allowing blood to flow only from the inlet end toward the outlet end of the stent; wherein stent stiffness provides the sole means of fixation to surrounding tissue for securing the stent and valve structure to the body channel and wherein the stent and valve structure are detachable from the catheter such that the catheter can be removed from the body channel and the inlet opening can be closed such that the stent and valve structure are permanently implantable in the body channel for replacing the function of a natural valve without suturing the stent or valve structure to surrounding native tissue.
Claim 19
Dependent Claim 15 words
The system according to claim 14 , wherein the stent comprises a grate shaped structure.
Claim 20
Dependent Claim 12 words
The system according to claim 15 , wherein the stent is self-expandable.
Claim 21
Dependent Claim 30 words
The system according to claim 16 , wherein the valve structure is formed of biological tissue before the valve prosthesis is introduced through the inlet opening into the body channel.
Claim 22
Dependent Claim 25 words
The system according to claim 17 , wherein the biological tissue forms two or more adjacent flaps, the flaps forming commissural points between adjacent flaps.
Claim 23
Dependent Claim 51 words
The system according to claim 18 , wherein the stent further comprises an outlet end portion configured for fixation in the ascending aorta at a location downstream of the coronary ostia and an inlet end portion configured for positioning the valve structure substantially between the coronary ostia and the left ventricle.
Claim 24
Dependent Claim 20 words
The system according to claim 19 , wherein at least the inlet end portion of the stent is substantially cylindrical.

References Cited (Backward Citations)

US3409013A Cited
US3587115A Cited
US3548417A Cited
GB1268484A Cited
US3671979A Cited
US3657744A Cited
US3714671A Cited
US3755823A Cited
US4035849A Cited
US4106129A Cited
US4056854A Cited
US4297749A Cited
US4222126A Cited
US4265694A Cited
US4574803A Cited
US4343048A Cited
GB2056023B Cited
US4373216A Cited
US4339831A Cited
US4470157A Cited
US4345340A Cited
US4406022A Cited
US4655771A Cited
US4655771B1 Cited
EP0103546B1 Cited
US4605407A Cited
US4535483A Cited
US4612011A Cited
EP0144167B1 Cited
US4787899A Cited
US5026366A Cited
US4592340A Cited
US4979939A Cited
US4787901A Cited
US4687483A Cited
US4643732A Cited
US4759758A Cited
US4733665B1 Cited
US4733665C2 Cited
US4733665A Cited
US4922905A Cited
US4692164A Cited
US4878906A Cited
US4777951A Cited
US4762128A Cited
US4883458A Cited
US4878495A Cited
US4796629A Cited
US4829990A Cited
US4851001A Cited
US5266073A Cited
US5032128A Cited
US5080668A Cited
US5007896A Cited
US4856516A Cited
US4966604A Cited
US4994077A Cited
US5500014A Cited
US5609626A Cited
US5047041A Cited
US4986830A Cited
US5089015A Cited
US5591185A Cited
US5037434A Cited
US5059177A Cited
US5840081A Cited
US6168614B1 Cited
US5085635A Cited
US5411552A Cited
EP0592410B1 Cited
US5152771A Cited
US5282847A Cited
US5607464A Cited
US5360444A Cited
US5443446A Cited
US5295958A Cited
US5167628A Cited
US5397351A Cited
US5769812A Cited
US5545214A Cited
EP0597967B1 Cited
US5370685A Cited
US5192297A Cited
US5756476A Cited
US5163953A Cited
US5665115A Cited
US5332402A Cited
US5411055A Cited
US5549665A Cited
US5545209A Cited
US5480424A Cited
US6302906B1 Cited
US5800508A Cited
US5728068A Cited
US5554185A Cited
US5639274A Cited
US5716417A Cited
US5571175A Cited
US6027525A Cited
US5855601A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2013-09-06 2014-03-08 2014-09-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2017-09-06 2018-03-08 2018-09-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2021-09-06 2022-03-08 2022-09-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag